Join Drs. Neha Pagidipati, Christie Ballantyne, and Gregory Piazza in a lively discussion on ASCVD management, including nonstatin therapies, challenges in patient care, and alternative treatment options. Explore the evolution towards combination therapy, considerations for statin-intolerant patients, and the importance of personalized treatment plans. Delve into the efficacy and tolerability of PCSK9 inhibitors and azetamide for statin-hesitant patients, and the benefits of combining medications to lower LDL cholesterol effectively in high-risk patients.
